| i3 is a global pharmaceutical services business providing integrated strategies and solutions throughout the product lifecycle. Our unique combination of products, services and knowledge helps companies gain sharper insights that lead to better patient care.
i3 Research
i3 Research is a full-service CRO focused on four CORE areas: central nervous system, oncology, respiratory and infectious diseases and endocrinology and metabolic disease. Therapeutic specialization drives all aspects of business in this global CRO. This CRO has capabilities in more than 45 countries, conducting research phases I through IV.
i3 Pharma Resourcing
i3 Pharma Resourcing draws on deep understanding of clinical trials to provide unmatched multinational clinical research staffing on either an individual or project team basis. i3 Pharma Resourcing is a strong complement to i3’s array of research and development services.
i3 Drug Safety
i3 Drug Safety provides comprehensive pharmacoepidemiology and pharmacovigilance services. Rooted in scientific rigor, using innovative methods and proven expertise, i3 Drug Safety’s services can be customized for all scopes of work, from safety surveillance and risk assessment in clinical development to post-approval pharmacovigilance.
i3 Innovus
i3 Innovus is a leading provider of health economics and outcomes research and marketing informatics solutions to help clients realize the full potential of their brands. i3 Innovus delivers real-world evidence that demonstrates the value to help products succeed in the market.
i3 Statprobe
i3 Statprobe focuses exclusively on providing the pharmaceutical and biotech industries with comprehensive, integrated data service solutions that include data capture, summary, analysis and reporting for clinical trials across all phases of research.
i3 CME
i3 CME is a full-service, accredited provider of continuing medical education. Using dynamic multimedia technology such as satellite broadcasting, as well as traditional methods, i3 CME delivers clinical expertise in several therapeutic areas, most notably CNS, oncology, cardiology and infectious disease. |